UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000049423
Receipt No. R000056275
Scientific Title Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3
Date of disclosure of the study information 2025/01/01
Last modified on 2022/11/04 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3
Acronym Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3
Scientific Title Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3
Scientific Title:Acronym Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3
Region
Japan

Condition
Condition Healthy person
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Confirm the effect of improving skin condition, mainly skin elasticity, when taking the test product for 3 months
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Skin elasticity (probe 6mm)
Key secondary outcomes *Secondary index
[1] Skin elasticity (probe 2mm)
[2] Wrinkle evaluation value by doctors
[3]Questionnaire of physical feeling
*Safety
[1]Doctor's questions
*Other index
[1]Subject's diary

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Ingestion of test food containing plant mixed extract A and plant mixed extract B (Tablets) for 12 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
35 years-old <=
Age-upper limit
50 years-old >=
Gender Female
Key inclusion criteria 1. Those who indicate their intention to participate in the test, understand the explanation, and obtain written consent to participate in the test
2. Healthy Japanese women between the ages of 35 and 50 who do not meet the exclusion criteria
3. Those who can fill in documents such as consent forms, questionnaires, test product intake diaries, etc.
4. Subjects who have felt effects on the skin with supplements, etc.
5. Subjects who feel a decrease in skin firmness
6. Mainly Grade 1 to 3 on the outer corner of the eye (Journal of the Japanese Cosmetic Science Society, 2006, Vol. 30, No. 4)
Persons with wrinkles corresponding to p316-322)
7. People with dry skin
8. Those who have menopausal symptoms (any symptoms)
Flushed face, sweating easily, lower back and limbs getting cold easily, shortness of breath/palpitations, difficulty falling asleep/shallow sleep, irritability and irritability, drowsiness/depression, headache/dizziness/nausea are common , Stiff shoulders, back pain, pain in limbs
9. Those who feel easily tired
Key exclusion criteria Those who meet even one of the following conditions will be excluded.
1. Those who currently use skin care and diet supplements, collagen supplements, and pharmaceuticals on a regular basis
2. Persons who cannot abstain from drinking from the day before the measurement to the end of the measurement
3. Those who smoke on a daily basis
4. Person with asthma
5. Those who are pregnant or planning to become pregnant, those who are breastfeeding
6. Those who have hay fever (those who do not take hay fever medicine are allowed)
7. Persons with food allergies
8. Tests of ingesting other foods and drugs, and applying cosmetics and drugs
who are currently participating in a similar study or who have been participating in a similar study for at least 3 months
who have not passed
9. Others who are judged to be inappropriate by the principal investigator
Target sample size 25

Research contact person
Name of lead principal investigator
1st name Osamu
Middle name
Last name Ueda
Organization Shiseido Co., Ltd.
Division name MIRAI Technology Institute
Zip code 220-0011
Address 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, Japan
TEL 045-222-1600
Email osamu.ueda@shiseido.com

Public contact
Name of contact person
1st name Kanako
Middle name
Last name Sakurai
Organization Inforward Co., Ltd.
Division name Ebisu Skin Research Center
Zip code 150-0013
Address 5th floor, 1-11-2 Ebisu, Shibuya-ku, Tokyo
TEL 03-5793-8712
Homepage URL
Email sakurai@inforward.co.jp

Sponsor
Institute Shiseido Co., Ltd.
Institute
Department

Funding Source
Organization Shiseido Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization General Incorporated Association Crinical Rese arch Review Center
Address 2972-8-603 Ishikawamachi Hachioji-shi,Toky o,192-0032,JAPAN
Tel 090-3547-6398
Email crrctakashima@kpd.biglobe.ne.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2025 Year 01 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 09 Month 29 Day
Date of IRB
Anticipated trial start date
2022 Year 11 Month 04 Day
Last follow-up date
2023 Year 03 Month 04 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 11 Month 04 Day
Last modified on
2022 Year 11 Month 04 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056275